Longeveron (LGVN) Shares Outstanding (Diluted) (2021 - 2026)
Longeveron (LGVN) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 52.24 Mn |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn | 256.30 Mn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | 680.00 |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | 64.41 Mn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 138.23 Mn |
| 10 | Longeveron | 15.28 Bn | 15.26 Bn | 264,000.00 | 24.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.79 Bn |
| Dec 31, 2025 | 17.58 Bn |
| Sep 30, 2025 | 18.37 Bn |
| Jun 30, 2025 | 15.01 Bn |
| Mar 31, 2025 | 14.95 Bn |
| Dec 31, 2024 | 9.41 Bn |
| Sep 30, 2024 | 13.63 Bn |
| Jun 30, 2024 | 6.51 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Dec 31, 2023 | 2.17 Mn |
| Sep 30, 2023 | 2.12 Mn |
| Jun 30, 2023 | 2.11 Mn |
| Mar 31, 2023 | 2.10 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Sep 30, 2022 | 2.10 Mn |
| Jun 30, 2022 | 2.09 Mn |
| Mar 31, 2022 | 2.09 Mn |
| Dec 31, 2021 | 1.89 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 1.90 Mn |